FDA NDC Directory · JSON-LD · Markdown

eribulin mesylate

NDC 60505-6435 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA218047
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsERIBULIN MESYLATE (.5 mg/mL)
Marketing started20250319
Package count1

External sources

Source: openFDA. Public-domain (CC0).